Overview

Using Three Different Doses of Hyperbaric Prilocaine 2% Local Anaesthetic ( 40,50 and 60mg ),Through Spinal Anaesthesia in Knee Arthroscopy Patients to Compare Time to Void

Status:
RECRUITING
Trial end date:
2025-06-15
Target enrollment:
Participant gender:
Summary
The goal of this randomised trial is to use a short acting local anaesthetic drug (hyperbaric prilocaine 2%) which is beneficial in short operations which are performed as a day case surgery. in this study the investigators will use 3 different doses of prilocaine 2% (40,50 or 60 mg ) intrathecal (in spinal anaesthesia) in participants undergoing arthroscopy on the knee. the primary outcome is to compare time to micturate (go to the bathroom) between the three groups . the secondary outcomes are: * time to recovery of the motor and sensory block * time to discharge from post anesthesia care unit * any complications ; itching, lowered blood pressure, nausea and vomiting.
Phase:
PHASE3
Details
Lead Sponsor:
Cairo University